Advertisement

Topics

POINT: Chemotherapy vs Abiraterone for the Initial Management of Metastatic Prostate Cancer

10:00 EDT 15 May 2018 | Cancer Networks

Chemotherapy is the best option for the initial management of metastatic prostate cancer.

Original Article: POINT: Chemotherapy vs Abiraterone for the Initial Management of Metastatic Prostate Cancer

NEXT ARTICLE

More From BioPortfolio on "POINT: Chemotherapy vs Abiraterone for the Initial Management of Metastatic Prostate Cancer"

Advertisement
Quick Search
Advertisement
Advertisement